The Chilkoti group carries out research in two areas: (1) Biomolecular Materials, with a focus on genetically encoded stimulus responsive peptide polymers and fusion proteins for application in protein purification and drug delivery; and (2) Biointerface Science, with a focus on protein-polymer conjugates, the development of low-cost, point-of-care clinical diagnostics, and plasmonic biosensors.
“Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity”, Journal of Controlled Release, vol. 269, pp. 364-373, 2018.,
“Injectable tissue integrating networks from recombinant polypeptides with tunable order”, Nature Materials, 2018.,